Henning Lux (CEO)

Henning Lux has more than 10 years of experience in software development for the pharma and life science industry. In 1996 he commenced the development of trialink, an internet based EDC system which was successfully brought to market in 1998. He has assisted numerous major pharmaceutical companies in their implementation of EDC and has been responsible for the roll-out of more than 50 trials.
Together with Quadratek Ltd. he founded QDS in 2003, his aim being to improve the conduct of electronic trials by eliminating the obstacles encountered with the day-to-day operation of EDC.

Ian Mills (CTO)

Ian Mills brings 18 years software development and consulting experience to QDS, with half of that experience gained in solutions for the pharmaceutical industry. Ian worked as a consultant at IBM where he was involved in the development and roll out of life science solutions. Prior to joining QDS in 2004 he was the CTO at a well known EDC solutions provider, where he was responsible for leading the software development.

Ian Bradbrook (Director of Clinical Operations)

Ian Bradbrook brings 30 years of experience in various aspects of the conduct of clinical trials. A graduate in chemistry from the University of London he performed research in the field of human pharmacokinetics and published many scientific papers in cooperation with other members of the staff at Guys Hospital, London. As a result of this experience he co-founded Guys Drug Research Unit (GDRU Ltd) with the aim of providing a centre of excellence for the conduct of Phase I/II studies on behalf of the pharmaceutical industry. Since leaving GDRU after serving 13 years as a Director he has been involved with the introduction of EDC technology in the clinical trials process for a number of pharmaceutical companies.